Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q2 2024 Earnings Call Transcript August 7, 2024
Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.07, expectations were $0.005.
Operator: Good afternoon and thank you for standing by. Welcome to the Sarepta Therapeutics Second Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator...
